Enhancing TRANslational SAFEty Assessment through Integrative Knowledge Management
eTRANSAFE project aims to develop an advanced data integration infrastructure together with innovative computational methods to improve the security in drug development process. The eTRANSAFE project aims at improving the safety assessment across the drug discovery and development process by applying bioinformatics approaches to shared preclinical and clinical data to systematically analyse the translatability of effects. Thus, enabling the optimisation of resources and the development of safer medicines.
eTRANSAFE has a duration of 5 years with an indicative budget of 40 Million Euro and is formed by a consortium of 8 academic institutions, 6 SMEs and 12 pharmaceutical companies. The project has been sponsored mainly by the European Union’s Horizon 2020 research and innovation programme and the European pharmaceutical industry (via EFPIA) under the auspices of the Innovative Medicines Initiative 2 Joint Undertaking.